Insulin Analog [EPC]

346454 reported adverse events

Drugs of this class: INSULIN ASPART INSULIN GLARGINE INSULIN LISPRO INSULIN DEGLUDEC INSULIN DETEMIR INSULIN GLARGINE-YFGN INSULIN GLARGINE-AGLR (INSULIN DEGLUDEC AND LIRAGLUTIDE) INSULIN ASPART INJECTION INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 68572
1 BLOOD GLUCOSE DECREASED 17114
2 DRUG INEFFECTIVE 16767
3 NAUSEA 14087
4 INCORRECT DOSE ADMINISTERED 12027
5 VISUAL IMPAIRMENT 11538
6 HYPOGLYCAEMIA 10987
7 MALAISE 9958
8 FATIGUE 9943
9 DIARRHOEA 9772
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 2009 0.6897
1 HYPOGLYCAEMIC UNCONSCIOUSNESS 1192 0.6492
2 HYPOGLYCAEMIC SEIZURE 410 0.5037
3 DIABETIC RETINOPATHY 1328 0.4608
4 BLOOD GLUCOSE FLUCTUATION 4075 0.4243
5 BLOOD GLUCOSE INCREASED 68572 0.4139
6 INSULIN RESISTANCE 706 0.4117
7 BLOOD GLUCOSE DECREASED 17114 0.4036
8 BLOOD GLUCOSE ABNORMAL 5819 0.3698
9 HYPOGLYCAEMIC COMA 888 0.3532
See all enriched reactions for Insulin Analog [EPC]